Advanced Medical Solutions Group plc (LON:AMS - Get Free Report) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 203.91 ($2.75) and traded as high as GBX 222.50 ($3.00). Advanced Medical Solutions Group shares last traded at GBX 221 ($2.98), with a volume of 325,905 shares changing hands.
Wall Street Analyst Weigh In
Several analysts have issued reports on AMS shares. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 275 price target on shares of Advanced Medical Solutions Group in a research note on Wednesday, July 16th. Peel Hunt reissued a "buy" rating and set a GBX 246 price target on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 17th. Finally, Berenberg Bank reissued a "buy" rating and set a GBX 300 price target on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 17th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, Advanced Medical Solutions Group has an average rating of "Buy" and an average target price of GBX 273.67.
View Our Latest Report on Advanced Medical Solutions Group
Advanced Medical Solutions Group Stock Up 2.1%
The stock has a market capitalization of £477.65 million, a P/E ratio of 6,800.00, a PEG ratio of 5.00 and a beta of 0.74. The company has a quick ratio of 4.58, a current ratio of 8.39 and a debt-to-equity ratio of 37.01. The firm has a 50 day simple moving average of GBX 208 and a two-hundred day simple moving average of GBX 203.91.
Advanced Medical Solutions Group (LON:AMS - Get Free Report) last announced its quarterly earnings results on Wednesday, September 17th. The company reported GBX 5.77 EPS for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. On average, equities research analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current year.
Insiders Place Their Bets
In other Advanced Medical Solutions Group news, insider A Christopher (Chris) Meredith sold 50,510 shares of the stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of GBX 218, for a total transaction of £110,111.80. Insiders own 4.13% of the company's stock.
About Advanced Medical Solutions Group
(
Get Free Report)
AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Advanced Medical Solutions Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Advanced Medical Solutions Group wasn't on the list.
While Advanced Medical Solutions Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.